Is Merck the Next Big Weight-Loss Stock?

Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs market.

Amidst an evolving field of competitors, the big pharma is committing a hearty chunk of cash in hopes of becoming a contender. But will that be enough to make it into the next great weight-loss stock? Let's investigate.

Merck on Dec. 16 said it had just inked a license agreement with a Chinese biopharma company called Hansoh Pharma that could presage its merits as a weight-loss stock in the coming years.

Source Fool.com